As 2021 comes to an end, this is our time to say thank you.

The film by Swiss-Indian filmmaker Kamal Musale is a contemporary drama and an epic biopic about Mother Teresa, which inspires to look at one's own values and to live compassion, respect and love in one's personal environment. A captivating movie that we at innoMedicus encourage you to watch.

Encouraging results of the world’s largest propensity matched comparison of salvage robot-assisted radical prostatectomy (RARP) after focal and whole gland nonsurgical primary therapy from the UK group has been published in the European Urology Open Science.

Treatment for high-risk non–muscle-invasive bladder cancer (NMIBC) with hyperthermic intravesical chemotherapy (HIVEC) using high-dose mitomycin-C (MMC) is safe, well tolerated, and appears efficacious after short-term follow-up, according to a report from Duke University urologists, which has been published in Urologic Oncology.

The first study to compare bi-parametric MRI, ultrasound and PSA as a screening test for prostate cancer has been recently published in JAMA Oncology.

The publication at The Journal of Urology entitled “High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series” details the study of 100 men with biopsy-confirmed prostate cancer, 72% of which were classified with intermediate or high-risk disease.

This year was a very challenging year for all of us. All the more we would like to thank you for your loyalty and for believing in us.

After the tremendous success of the FOCAL2019 in Miami, the annual conference on the Frontiers in Oncologic Prostate Care and Ablative Local Therapy FOCAL2020 took place virtually where a lot of participants from the world over attended this cutting-edge meeting despite Covid-19 restrictions.

mpMRI has dramatically changed how urologists diagnose and monitor prostate cancer, as it not only allows lesions to be targeted in biopsies but also helps in deciding which patients to biopsy.

Promising preliminary results from HIVEC-HR randomized trial with 24 months of median follow-up, presented by a group of urologists from the Hospital Universitario 12 de Octubre, Madrid, peaked great interest at AUA 2020, because of the growing need to find a valid alternative to BCG for patients with non-muscle invasive bladder cancer (NMIBC).

A group of urologists from Weill Cornell Medicine, New York, NY and Urological Research Network, Miami, FL has presented an interesting pilot study of the feasibility and reproducibility of performing MR/US cryoablation using the MR/US fusion from the Artemis® platform in a step-by-step video at AUA University podcast online.

The great editorial by Dr. Paul Cathcart, a UK expert of salvage robotic radical prostatectomy, has been recently published in the British Journal of Urology International.